University Of Texas Bio Path Holdings Inc Transaction History

University Of Texas

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$6.97 - $12.3 $133,510 - $235,606	-19,155 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$12.52 - $20.81 $12 - $20	1 Added 0.01%	19,155 $256,000
Q1 2019 May 01, 2019	BUY	$1.81 - $38.86 $34,668 - $744,324	19,154 New	19,154 $391,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $7.73M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

Stay updated on University Of Texas with notifications on news.